DNA Methylation and Uveal Melanoma / 中华医学杂志(英文版)

<p><b>Objective</b>The objective of the study was to summarize the role of DNA methylation in the development and metastasis of uveal melanoma (UM).</p><p><b>Data Sources</b>The relevant studies in MEDLINE were searched.</p><p><b>Study Selection</b>In this review, we performed a comprehensive literature search in MEDLINE using "uveal melanoma" AND ("DNA methylation" OR "epigenetics") for original research/review articles published before February 2018 on the relationship between DNA methylation and UM. References of the retrieved studies were also examined to search for potentially relevant papers.</p><p><b>Results</b>Previous studies on the relationship between DNA methylation and UM covered many genes including tumor suppressor genes (TSGs), cyclin-dependent kinase genes, and other genes. Among them, the TSG genes such as RASSF1A and p16INK4a, which encodes a cyclin-dependent kinase inhibitor, are relatively well-studied genes. Specifically, a high percentage of promoter methylation of RASSF1A was observed in UM cell lines and/or patients with UM. Promoter methylation of RASSF1A was also associated with the development of metastasis. Similarly, a high percentage of promoter hypermethylation of p16INK4a was found in UM cell lines. DNA promoter methylation can control the expression of p16INK4a, which affect cell growth, migration, and invasion in UM. Many other genes might also be involved in the pathogenesis of UM such as the Ras and EF-hand domain containing (RASEF) gene, RAB31, hTERT, embryonal fyn-associated substrate, and deleted in split-hand/split-foot 1.</p><p><b>Conclusions</b>Our review reveals the complex mechanisms underlying the tumorigenesis of UM and highlights the great needs of future studies to discover more genes/5'-C-phosphate-G-3' sites contributing to the development/metastasis of UM and explore the mechanisms through which epigenetic changes exert their function in UM.</p>

Tear film function of patients with type 2 diabetes / 中国医学科学院学报

<p><b>OBJECTIVE</b>To study the tear film function of patients with type 2 diabetes and to investigate the risk factors of dry eye in these patients.</p><p><b>METHODS</b>Totally 111 patients with type 2 diabetes and 100 age- and sex-matched control subjects were studied. Tear film function was evaluated by dry eye syndrome, tear breaking up time (BUT), corneal fluorescein staining, Schirmer I test (SIt), and tear film lipid layer observation with tear scope. Dye eye score was calculated with the results of these tests.</p><p><b>RESULTS</b>When compared with the controls, patients with type 2 diabetes showed higher dry eye score (diabetics 3.28 +/- 1.56, control 2.31 +/- 1.50, P < 0.01) and faster BUT [diabetics (6.50 +/- 4.84) s, control (12.26 +/- 7.16) s, P < 0.01], but similar SIt [diabetics (10.61 +/- 6.86) s, control (10.92 +/- 7.05) s, P > 0.05]. More diabetic patients were diagnosed as dry eye(diabetics 19.8%, control 8.0%, P < 0.05). According to their retinopathy, the diabetic patients were divided into three groups: without diabetic retinopathy (DR), with background DR, and with proliferative DR. For these three groups, the dry eye scores were 2.95 +/- 1.50, 3.38 +/- 1.48 and 4.11 +/- 1.60, respectively (P < 0.01); the SIt were (10.95 +/- 6.89) mm, (11.71 +/- 7.30) mm and (7.63 +/- 5.20) mm, respectively (P > 0.05); the BUT were (7.53 +/- 5.23) s, (5.88 +/- 4.10) s and (4.47 +/- 4.17) s (P < 0.05). Patients with DR were then devided into two groups: with photocoagulation and without photocoagulation. For these two groups, the dry eye scores were 4.71 +/- 1.14 and 3.26 +/- 1.15, respectively (P < 0.01); the BUT were (2.93 +/- 2.06) s and (6.26 +/- 4.36) s, respectively (P < 0.01); the SIt were (7.21 +/- 6.51) mm and (11.33 +/- 6.73) mm, respectively (P < 0.05); the rates of corneal fluorescein staining were 50.0% and 17.9%, respectively (P < 0.05). Dry eye score had a good correlation with diabetic retinopathy and photocoagulation (P < 0.01), but was poorly correlaed with age, gender, insulin, duration of diabetes mellitus, and metabolic control (P > 0.05).</p><p><b>CONCLUSIONS</b>Patients with type 2 diabetes tend to develop tear film dysfunction. The disorders of tear film quantity and quality seem relevant to the stage of diabetic retinopathy and photocoagulation.</p>